Word: sabine
(lookup in dictionary)
(lookup stats)
Dates: during 1960-1969
Sort By: most recent first
(reverse)
...infection, the U.S. Public Health Service called its committee on poliomyelitis control into session there to plan for the spring and summer campaign when the disease attacks again. Hostilities promptly broke out within the council of war itself, mainly over the relative merits of the Salk injected and the Sabin oral vaccines. The chief antagonists were the National Foundation's crusty perennial chairman, Basil O'Connor, and the University of Cincinnati's inventive, acidulous Dr. Albert B. Sabin...
...when it will be available, and the public, confused by talk of the two, may neglect to get the Salk shots. When Dr. John B. Johnson of the National (Negro) Medical Association contrasted the slow U.S. pace of oral vaccine development with Russia's high-speed drive,* Dr. Sabin snapped: "It requires leadership to get these things done. We simply need leadership." Dr. Robert N. Barr, representing state health officers, blew up: "That's a damned insult, Mr. Chairman! I object to that statement." But Sabin would not withdraw it. "The National Foundation has supported [with...
Certainly one of your selections should have been displaced by Dr. Albert Sabin, developer of one of the greatest humanitarian gifts to the world in many years-an orally administered vaccine for polio. Does he not rank somewhere in the list...
Capsule or Teaspoon. The Sabin vaccine, which, like the Salk, is grown in monkey kidney cells, has been tested on a small scale in the U.S. but used wholesale in the U.S.S.R., where almost 80 million people have now taken it in various forms and on different dosage schedules. Full protection against all three types of polio requires three virus strains, one of each type. Dr. Sabin has tried giving them separately at short intervals, as well as in a three-in-one dose. Best results to date have been with the spaced, single-type doses, and it is expected...
Import Later. Lederle officials, who have invested $13 million in developing the Cox product, were stunned by the PHS endorsement of Sabin vaccine, which was financed by March of Dimes funds and had the powerful support of the National Foundation. Also stunned was Dr. Hilary Koprowski, an early Lederle worker on the vaccine, now at Philadelphia's Wistar Institute. At issue was the question whether the Sabin vaccine was indeed safer than the Cox and Koprowski varieties, as the PHS implied...